EDEWOR OSEVWE: Open Payments
NPI 1386939429 · PEARLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,827 in 56 payments from 11 companies in 2025. Trend: 2023 $18 · 2024 $611 · 2025 $1,827
Food & beverage: $1,827
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $681 |
| Axsome Therapeutics, Inc. | 18 | $512 |
| Neurocrine BioSciences, Inc. | 2 | $137 |
| Luye Pharma (USA) Ltd. | 1 | $90 |
| Janssen Pharmaceuticals, Inc | 3 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $71 |
| Teva Pharmaceuticals USA, Inc. | 2 | $60 |
| Tempus AI, Inc | 2 | $58 |
| Lundbeck LLC | 2 | $50 |
Products named: CAPLYTA, Auvelity, REXULTI, ERZOFRI EXTENDED-RELEASE, INVEGA SUSTENNA, TRINTELLIX, TEMPUS PIXEL, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
